CECAD Institute of the University of Cologne
Oliver Cornely is Professor and Chair of Translational Research at the CECAD Institute of the University of Cologne. He is also Scientific Director of the Center for Clinical Trials, and Professor of Internal Medicine and Consultant in Infectious Diseases at the Department I of Internal Medicine, at the University Hospital of Cologne, Cologne, Germany.
He received his medical degree (1994) from the University Hospital at Albertus Magnus University, Cologne, where he also completed his residency. He is board certified in internal medicine, infectious diseases, haematology, oncology, and emergency medicine.
Originating from an HIV/AIDS clinical research group, Oliver Cornely’s research interest centers on infections in immunocompromised hosts, including invasive fungal diseases, antimicrobial resistance and Clostridium difficile infection.
Oliver Cornely is past President of the European Confederation of Medical Mycology (ECMM), the roof organization of 24 national mycology societies, and did set up ECMM Guideline Program, ECMM Academy (Fellows program), and ECMM Excellence Center Initiative, designating clinical and microbiological centers after an international audit procedure. He currently serves on the Standards and Practice Guidelines Committee (SPGC) of the Infectious Diseases Society of America (IDSA), and on the Board of Directors of the Mycoses Study Group Education & Research Consortium (MSGERC). He is the founder and chair of the Infectious Diseases Scientific Working Group of the European Hematology Association (EHA). Prof. Cornely has published over 300 peer-reviewed articles. He is a reviewer for numerous medical scientific journals, editorial board member for Haematologica, Infectious Disease, and Editor-in-Chief of Mycoses.